Pfizer
PFE
PFE
2,865 hedge funds and large institutions have $105B invested in Pfizer in 2024 Q2 according to their latest regulatory filings, with 212 funds opening new positions, 1,178 increasing their positions, 1,238 reducing their positions, and 172 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
5% less repeat investments, than reductions
Existing positions increased: 1,178 | Existing positions reduced: 1,238
1.16% less ownership
Funds ownership: 67.1% → 65.94% (-1.2%)
40% less call options, than puts
Call options by funds: $2.36B | Put options by funds: $3.9B
Holders
2,865
Holding in Top 10
33
Calls
$2.36B
Puts
$3.9B
Top Buyers
| 1 | +$346M | |
| 2 | +$334M | |
| 3 | +$233M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$217M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$199M |
Top Sellers
| 1 | -$675M | |
| 2 | -$437M | |
| 3 | -$313M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$222M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$220M |